Summary
Definitions
- Macule: a flat area of color change <1 cm in size (e.g., viral exanthem [such as measles and rubella], morbilliform drug eruption).
- Patch: a large macule >1 cm in size (e.g., viral exanthem [such as measles and rubella], morbilliform drug eruption).
- Papule: a raised area <1 cm in size (e.g., wart).
- Nodule: a larger papule, >1 cm in size (e.g., nodular prurigo).
- Plaque: a flat-topped raised area (a cross between a nodule and a patch; e.g., psoriasis).
- Vesicle: a small fluid-filled lesion (blister) <0.5 cm in size (e.g., varicella, eczema herpeticum).
- Bulla: a larger vesicle >0.5 cm (e.g., bullous impetigo).
- Pustule: a pus-filled lesion (e.g., folliculitis).
- Wheal: a transient raised papule or plaque caused by dermal edema (e.g., urticaria).
- Scale: flakes of stratum corneum (e.g., eczema, psoriasis).
- Crust: dried serum, blood, or purulent exudate on the skin surface (e.g., impetigo).
- Erosion: loss of epidermis, heals without scarring (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis).
- Ulcer: loss of epidermis and dermis, heals with scarring (e.g., venous ulcer, pyoderma gangrenosum).
- Excoriation: loss of epidermis following trauma such as scratching (e.g., as can be seen in eczema).
- Fissure: a split in the skin (e.g., angular cheilitis, palmoplantar keratoderma).
- Lichenification: thickening of the skin with accentuation of skin markings (e.g., chronic eczema, lichen simplex chronicus).
- Purpura: an area of color change (red or purple) due to bleeding into the skin; does not blanch on pressure (e.g., vasculitis, disseminated intravascular coagulation).
- Petechia: a pin-point purpuric lesion (e.g., vasculitis, disseminated intravascular coagulation).
- Ecchymosis: a larger area of purpura (e.g., vasculitis, disseminated intravascular coagulation).
- Annular: ringed lesions.
- Malar: also known as "butterfly rash"; a symmetrical fixed erythematous maculopapular lesion with slight scale occurring over both cheeks and nose, sparing the nasolabial folds.
Library
Stevens-Johnson syndrome: targetoid lesions and epidermal loss
Stevens-Johnson syndrome: epidermal loss on soles of feet
Toxic epidermal necrolysis with epidermal loss, ocular involvement, and ecthyma gangrenosum
Janeway lesions
Osler node
Roth spots
Staphylococcal scalded skin syndrome
Rash and subcutaneous edema of the right hand due to toxic shock syndrome
Marked desquamation of the left palm due to toxic shock syndrome, which develops late in the disease
Petechial rash in invasive meningococcal disease
Typical appearance of erythema marginatum on the back of a child with acute rheumatic fever
Palpable purpura on the lower extremities of a child with immunoglobulin A (IgA) vasculitis (formerly known as Henoch-Schonlein purpura)
Immunoglobulin A (IgA) vasculitis (formerly known as Henoch-Schonlein purpura): purpura mainly affects the legs, up to the gluteal muscles, inflaming the joints of the ankle and knee, but can also affect the arms and elbow
Hypersensitivity rash due to penicillin
The scarlet fever rash first appears as tiny red bumps on the chest and abdomen that may spread all over the body; looking like sunburn, it feels like a rough piece of sandpaper, and lasts about 2 to 5 days
Erythema migrans in Lyme disease
Child with measles showing the characteristic red blotchy rash on his buttocks and back during the third day of the rash
Koplik spots
Maculopapular and petechial rash of Rocky Mountain spotted fever
Typical erythematous slapped cheeks of erythema infectiosum
Varicella lesions in young boy
This newborn presented with symptoms of congenital syphilis that included lesions on the soles of both feet
Herald patch
Acute atopic dermatitis in the antecubital fossa of a 9-year-old girl
Maculopapular inflammatory rash on the abdomen due to scabies. Of importance, is how this rash appears to resemble many other breakouts, including measles and chickenpox
Facial impetigo
Citations
Johnston GA, Exton LS, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of contact dermatitis 2017. Br J Dermatol. 2017 Feb;176(2):317-29.[Abstract]
National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. Mar 2024 [internet publication].[Full Text]
National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. Nov 2021 [internet publication].[Full Text]
1. Knöpfel N, Noguera-Morel L, Latour I, et al. Viral exanthems in children: a great imitator. Clin Dermatol. 2019 May - Jun;37(3):213-26.[Abstract]
2. van Lier A, Smits G, Mollema L, et al. Varicella zoster virus infection occurs at a relatively young age in The Netherlands. Vaccine. 2013 Oct 17;31(44):5127-33.[Abstract]
3. Chovel-Sella A, Ben Tov A, Lahav E, et al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics. 2013 May;131(5):e1424-7.[Abstract]
4. Drago F, Ciccarese G, Gasparini G, et al. Contemporary infectious exanthems: an update. Future Microbiol. 2017 Feb;12:171-93.[Abstract][Full Text]
5. Castro MCR, Ramos-E-Silva M. The rash with mucosal ulceration. Clin Dermatol. 2020 Jan - Feb;38(1):35-41.[Abstract]
6. Repass GL, Palmer WC, Stancampiano FF. Hand, foot, and mouth disease: identifying and managing an acute viral syndrome. Cleve Clin J Med. 2014 Sep;81(9):537-43.[Abstract][Full Text]
7. Fölster-Holst R. Infectious exanthemas in childhood. J Dtsch Dermatol Ges. 2020 Oct;18(10):1128-55.[Abstract][Full Text]
8. Chuh A, Zawar V, Sciallis GF, et al. Pityriasis rosea, Gianotti-Crosti syndrome, asymmetric periflexural exanthem, papular-purpuric gloves and socks syndrome, eruptive pseudoangiomatosis, and eruptive hypomelanosis: do their epidemiological data substantiate infectious etiologies? Infect Dis Rep. 2016 Mar 21;8(1):6418.[Abstract][Full Text]
9. Centers for Disease Control and Prevention. Measles cases and outbreaks: measles cases in 2024. Apr 2024 [internet publication].[Full Text]
10. UK Health Security Agency. National measles standard incident - measles epidemiology (from October 2023). Jun 2024 [internet publication].[Full Text]
11. Karnad DR, Richards GA, Silva GS, et al. Tropical diseases in the ICU: a syndromic approach to diagnosis and treatment. J Crit Care. 2018 Aug;46:119-26.[Abstract]
12. Freeman EE, McMahon DE, Lipoff JB, et al. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020 Aug;83(2):486-92.[Abstract][Full Text]
13. Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: part 1. Clin Exp Dermatol. 2021 Apr;46(3):444-50.[Abstract]
14. Almeida G, Arruda S, Marques E, et al. Presentation and management of cutaneous manifestations of COVID-19. J Drugs Dermatol. 2021 Jan 1;20(1):76-83.[Abstract][Full Text]
15. Baradaran A, Malek A, Moazzen N, et al. COVID-19 associated multisystem inflammatory syndrome: a systematic review and meta-analysis. Iran J Allergy Asthma Immunol. 2020 Dec 19;19(6):570-88.[Abstract][Full Text]
16. Bryant MC, Spencer LT, Yalcindag A. A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature. Pediatr Rheumatol Online J. 2022 Aug 13;20(1):65.[Abstract][Full Text]
17. Panda M, Agarwal A, Hassanandani T. Dermatological manifestations of COVID-19 in children. Indian Pediatr. 2022 May 15;59(5):393-9.[Abstract]
18. Toraih EA, Hussein MH, Elshazli RM, et al. Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis. World J Pediatr. 2021 Apr;17(2):141-51.[Abstract][Full Text]
19. Blatz AM, Oboite M, Chiotos K, et al. Cutaneous findings in SARS-CoV-2-associated multisystem inflammatory disease in children. Open Forum Infect Dis. 2021 Mar;8(3):ofab074.[Abstract][Full Text]
20. Karadag AS, Elmas ÖF, Altunay İK. Cutaneous manifestations associated with HIV infections: A great imitator. Clin Dermatol. 2020 Mar-Apr;38(2):160-75.[Abstract]
21. Huang YA, Howard-Jones AR, Durrani S, et al. Monkeypox: a clinical update for paediatricians. J Paediatr Child Health. 2022 Sep;58(9):1532-8.[Abstract][Full Text]
22. World Health Organization. Clinical management and infection prevention and control for monkeypox: interim rapid response guidance, 10 June 2022. Jun 2022 [internet publication].[Full Text]
23. World Health Organization. Mpox. Aug 2024 [internet publication].[Full Text]
24. Petersen E, Kantele A, Koopmans M, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019 Dec;33(4):1027-43.[Abstract][Full Text]
25. Centers for Disease Control and Prevention. Mpox: case definition. Sep 2024 [internet publication].[Full Text]
26. McCollum AM, Shelus V, Hill A, et al. Epidemiology of human mpox - worldwide, 2018-2021. MMWR Morb Mortal Wkly Rep. 2023 Jan 20;72(3):68-72.[Abstract][Full Text]
27. National Institute for Health and Care Excellence. Atopic eczema in under 12s: diagnosis and management. Jun 2023 [internet publication].[Full Text]
28. Ho T, Taylor MT, Marathe KS, et al. Most common pediatric skin conditions managed in outpatient dermatology clinics in the United States stratified by race and ethnicity. Pediatr Dermatol. 2021 Nov;38 Suppl 2:129-31.[Abstract][Full Text]
29. Victoire A, Magin P, Coughlan J, et al. Interventions for infantile seborrhoeic dermatitis (including cradle cap). Cochrane Database Syst Rev. 2019 Mar 4;(3):CD011380.[Abstract][Full Text]
30. Milingou M, Tagka A, Armenaka M, et al. Patch tests in children: a review of 13 years of experience in comparison with previous data. Pediatr Dermatol. 2010 May-Jun;27(3):255-9.[Abstract]
31. Johnston GA, Exton LS, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of contact dermatitis 2017. Br J Dermatol. 2017 Feb;176(2):317-29.[Abstract]
32. Marji JS, Marcus R, Moennich J, et al. Use of biologic agents in pediatric psoriasis. J Drugs Dermatol. 2010 Aug;9(8):975-86.[Abstract]
33. Zawar V. Unilateral pityriasis rosea in a child. J Dermatol Case Rep. 2010 Dec 31;4(4):54-6.[Abstract][Full Text]
34. Hay RJ, Steer AC, Engelman D, et al. Scabies in the developing world - its prevalence, complications, and management. Clin Microbiol Infect. 2012 Apr;18(4):313-23.[Abstract]
35. Fuller LC, Barton RC, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014 Sep;171(3):454-63.[Abstract][Full Text]
36. Cohen B. Differential diagnosis of diaper dermatitis. Clin Pediatr (Phila). 2017 May;56(5_suppl):16S-22S.[Abstract][Full Text]
37. Lebsing S, Chaiyarit J, Techasatian L. Diaper rashes can indicate systemic conditions other than diaper dermatitis. BMC Dermatol. 2020 Sep 21;20(1):7.[Abstract][Full Text]
38. McFee RB. Tick borne illness - Rocky mountain spotted fever. Dis Mon. 2018 May;64(5):185-94.[Abstract]
39. National Institute for Health and Care Excellence. Lyme disease. Oct 2018 [internet publication].[Full Text]
40. Hoetzenecker W, Nägeli M, Mehra ET, et al. Adverse cutaneous drug eruptions: current understanding. Semin Immunopathol. 2016 Jan;38(1):75-86.[Abstract]
41. Waldman R, Whitaker-Worth D, Grant-Kels JM. Cutaneous adverse drug reactions: kids are not just little people. Clin Dermatol. 2017 Nov - Dec;35(6):566-82.[Abstract]
42. Belum VR, Benhuri B, Postow MA, et al. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor. Eur J Cancer. 2016 Jun;60:12-25.[Abstract][Full Text]
43. Miliszewski MA, Kirchhof MG, Sikora S, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: an analysis of triggers and implications for improving prevention. Am J Med. 2016 Nov;129(11):1221-5.[Abstract]
44. Bauer KA, Brimhall AK, Chang TT. Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with azithromycin in acute Epstein-Barr virus infection. Pediatr Dermatol. 2011 Nov-Dec;28(6):741-3.[Abstract]
45. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol. 2013 May;68(5):693.e1-14; quiz 706-8.[Abstract]
46. Adwan MH. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and the rheumatologist. Curr Rheumatol Rep. 2017 Jan;19(1):3.[Abstract]
47. Ramien M, Goldman JL. Pediatric SJS-TEN: where are we now? F1000Res. 2020;9(Faculty Rev):982.[Abstract][Full Text]
48. Meningitis Research Foundation. Meningococcal meningitis and sepsis: guidance notes. 2018 [internet publication].[Full Text]
49. O'Byrne P, MacPherson P. Syphilis. BMJ. 2019 Jun 28;365:l4159.[Abstract][Full Text]
50. Florez-Pollack S, Mauskar MM. Disseminated gonococcal infection. N Engl J Med. 2019 Apr 18;380(16):1565.[Abstract]
51. Kelchtermans J, Grossar L, Eyskens B, et al. Clinical characteristics of infective endocarditis in children. Pediatr Infect Dis J. 2019 May;38(5):453-8.[Abstract]
52. Baltimore RS, Gewitz M, Baddour LM, et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young and the Council on Cardiovascular and Stroke Nursing. Infective endocarditis in childhood: 2015 update: a scientific statement from the American Heart Association. Circulation. 2015 Oct 13;132(15):1487-515.[Abstract][Full Text]
53. Mazori DR, Nagarajan S, Glick SA. Recurrent reactive infectious mucocutaneous eruption (RIME): insights from a child with three episodes. Pediatr Dermatol. 2020 May;37(3):545-7.[Abstract]
54. Brewer JD, Hundley MD, Meves A, et al. Staphylococcal scalded skin syndrome and toxic shock syndrome after tooth extraction. J Am Acad Dermatol. 2008 Aug;59(2):342-6.[Abstract]
55. Strom MA, Hsu DY, Silverberg JI. Prevalence, comorbidities and mortality of toxic shock syndrome in children and adults in the USA. Microbiol Immunol. 2017 Nov;61(11):463-73.[Abstract][Full Text]
56. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022 Mar;77(3):734-66.[Abstract][Full Text]
57. Najib U, Sheikh J. An update on acute and chronic urticaria for the primary care provider. Postgrad Med. 2009 Jan;121(1):141-51.[Abstract]
58. Chafen JJ, Newberry SJ, Riedl MA, et al. Diagnosing and managing common food allergies: a systematic review. JAMA. 2010 May 12;303(18):1848-56.[Abstract]
59. Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatr Clin North Am. 2013 Dec;60(6):1489-511.[Abstract]
60. Rashtak S, Pittelkow MR. Skin involvement in systemic autoimmune diseases. Curr Dir Autoimmun. 2008;10:344-58.[Abstract]
61. Webb RH, Grant C, Harnden A. Acute rheumatic fever. BMJ. 2015 Jul 14;351:h3443.[Abstract]
62. Miyake CY, Gauvreau K, Tani LY, et al. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics. 2007 Sep;120(3):503-8.[Abstract]
63. Hornor G. Medical evaluation for child physical abuse: what the PNP needs to know. J Pediatr Health Care. 2012 May-Jun;26(3):163-70; quiz 171-3.[Abstract]
64. Mohandas P, Ravenscroft JC, Bewley A. Dermatitis artefacta in childhood and adolescence: a spectrum of disease. G Ital Dermatol Venereol. 2018 Aug;153(4):525-34.[Abstract]
65. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10.[Abstract][Full Text]
66. National Institute for Health and Care Excellence. Suspected sepsis: recognition, diagnosis and early management. Mar 2024 [internet publication].[Full Text]
67. Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020 Feb;46(suppl 1):10-67.[Abstract][Full Text]
68. Schlapbach LJ, Watson RS, Sorce LR, et al. International consensus criteria for pediatric sepsis and septic shock. JAMA. 2024 Feb 27;331(8):665-74.[Abstract][Full Text]
69. Royal College of Physicians. National Early Warning Score (NEWS) 2. Dec 2017 [internet publication].[Full Text]
70. American College of Emergency Physicians (ACEP) Expert Panel on Sepsis. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. 2023 [internet publication].[Full Text]
71. Academy of Medical Royal Colleges. Statement on the initial antimicrobial treatment of sepsis. Oct 2022 [internet publication].[Full Text]
72. Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020 Apr;145(4):1082-123.[Abstract][Full Text]
73. Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024 Feb;132(2):124-76.[Abstract][Full Text]
74. Heckenberg SG, Brouwer MC, van de Beek D, et al. Bacterial meningitis. Handb Clin Neurol. 2014;121:1361-75.[Abstract]
75. National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. Mar 2024 [internet publication].[Full Text]
76. UK Health Security Agency. Scarlet fever: symptoms, diagnosis and treatment. Mar 2019 [internet publication].[Full Text]
77. UK Health Security Agency. Group A streptococcal infections: activity during the 2022 to 2023 season. Jun 2023 [internet publication].[Full Text]
78. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012 Nov 15;55(10):e86-102.[Abstract][Full Text]
79. Committee on Infectious Diseases, American Academy of Pediatrics; Kimberlin DW, Barnett ED, Lynfield R et al. Red Book: 2021-2024 Report of the Committee on Infectious Diseases. 32nd ed. American Academy of Pediatrics; 2021.[Full Text]
80. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009 Mar 24;119(11):1541-51.[Abstract][Full Text]
81. UK Health Security Agency. UKHSA update on scarlet fever and invasive group A strep. May 2023 [internet publication].[Full Text]
82. World Health Organization. Increased incidence of scarlet fever and invasive group A streptococcus infection - multi-country. Dec 2022 [internet publication].[Full Text]
83. Dixon G, Christov G. Infective endocarditis in children: an update. Curr Opin Infect Dis. 2017 Jun;30(3):257-67.[Abstract]
84. Webb R, Voss L, Roberts S, et al. Infective endocarditis in New Zealand children 1994-2012. Pediatr Infect Dis J. 2014 May;33(5):437-42.[Abstract]
85. Mathur AN, Mathes EF. Urticaria mimickers in children. Dermatol Ther. 2013 Nov-Dec;26(6):467-75.[Abstract]
86. Tabel Y, Inanc FC, Dogan DG, et al. Clinical features of children with Henoch-Schonlein purpura: risk factors associated with renal involvement. Iran J Kidney Dis. 2012 Jul;6(4):269-74.[Abstract]
87. Kellogg ND; American Academy of Pediatrics Committee on Child Abuse and Neglect. Evaluation of suspected child physical abuse. Pediatrics. 2007 Jun;119(6):1232-41.[Abstract][Full Text]
88. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-99.[Abstract][Full Text]
89. Jamieson N, Singh-Grewal D. Kawasaki disease: a clinician's update. Int J Pediatr. 2013;2013:645391.[Abstract][Full Text]
90. World Health Organization. Dengue and severe dengue. Mar 2023 [internet publication].[Full Text]
91. World Health Organization, Special Programme for Research and Training in Tropical Diseases (TDR). Dengue: guidelines for diagnosis, treatment, prevention and control. April 2009 [internet publication].[Full Text]
92. National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. Nov 2021 [internet publication].[Full Text]
93. American Academy of Pediatrics. Lyme disease. In: Kimberlin DW, Brady MT, Jackson MA, et al, eds. Red book 2018-2021: report of the Committee on Infectious Diseases. 31st ed. Elk Grove Village, IL: American Academy of Pediatrics; 2018:515-23.
94. UK Health Security Agency. National measles guidelines. Jul 2024 [internet publication].[Full Text]
95. UK Health Security Agency. Measles: the green book, chapter 21. Dec 2019 [internet publication].[Full Text]
96. Kimura H, Shirabe K, Takeda M, et al. The association between documentation of koplik spots and laboratory diagnosis of measles and other rash diseases in a National Measles Surveillance Program in Japan. Front Microbiol. 2019 Feb 18;10:269.[Abstract][Full Text]
97. Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States. MMWR Recomm Rep. 2016 May 13;65(2):1-44.[Abstract][Full Text]
98. World Health Organization, Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever - revised and expanded edition. 2011 [internet publication].[Full Text]
99. Premaratna R, Pathmeswaran A, Amarasekara ND, et al. A clinical guide for early detection of dengue fever and timing of investigations to detect patients likely to develop complications. Trans R Soc Trop Med Hyg. 2009 Feb;103(2):127-31.[Abstract]
100. Atanasković-Marković M, Janković J, Tmušić V, et al. Hypersensitivity reactions to antiepileptic drugs in children. Pediatr Allergy Immunol. 2019 Aug;30(5):547-52.[Abstract]
101. Van den Bruel A, Haj-Hassan T, Thompson M, et al. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010 Mar 6;375(9717):834-45.[Abstract]
102. Pite H, Wedi B, Borrego LM, et al. Management of childhood urticaria: current knowledge and practical recommendations. Acta Derm Venereol. 2013 Sep 4;93(5):500-8.[Abstract][Full Text]
103. Elzagallaai AA, Knowles SR, Rieder MJ, et al. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 2009;32(5):391-408.[Abstract]
104. Shi YW, Min FL, Zhou D, et al. HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions. Neurology. 2017 Jun 6;88(23):2183-91.[Abstract][Full Text]
105. Saito M, Yagi M, Uno K, et al. Comparative study of the usefulness of the drug-induced lymphocyte stimulation test and the leukocyte migration test in drug allergies. Biol Pharm Bull. 2008 Feb;31(2):299-304.[Abstract][Full Text]
106. Centres for Disease Control and Prevention. Clinical recognition: key characteristics for identifying Mpox. Mar 2023 [internet publication].[Full Text]
107. Li P, Li J, Ayada I, et al. Clinical features, antiviral treatment, and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks. J Infect Dis. 2023 Aug 16;228(4):391-401.[Abstract][Full Text]
108. Hatami H, Jamshidi P, Arbabi M, et al. Demographic, epidemiologic, and clinical characteristics of human monkeypox disease pre- and post-2022 outbreaks: a systematic review and meta-analysis. Biomedicines. 2023 Mar 20;11(3):957.[Abstract][Full Text]
109. MacNeil A, Reynolds MG, Carroll DS, et al. Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo. Am J Trop Med Hyg. 2009 Apr;80(4):503-7.[Abstract]
110. Hoff NA, Morier DS, Kisalu NK, et al. Varicella coinfection in patients with active monkeypox in the Democratic Republic of the Congo. Ecohealth. 2017 Sep;14(3):564-74.[Abstract][Full Text]
111. Hughes CM, Liu L, Davidson WB, et al. A tale of two viruses: coinfections of monkeypox and varicella zoster virus in the Democratic Republic of Congo. Am J Trop Med Hyg. 2020 Dec 7;104(2):604-11.[Abstract][Full Text]
112. Cooper JM, Sánchez PJ. Congenital syphilis. Semin Perinatol. 2018 Apr;42(3):176-84.[Abstract][Full Text]
113. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015-38.[Abstract]
114. Menter A, Cordoro KM, Davis DMR, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020 Jan;82(1):161-201.[Abstract][Full Text]
115. Chadha A, Jahnke M. Common neonatal rashes. Pediatr Ann. 2019 Jan 1;48(1):e16-e22.[Abstract]
116. Reginatto FP, Villa DD, Cestari TF. Benign skin disease with pustules in the newborn. An Bras Dermatol. 2016 Apr;91(2):124-34.[Abstract][Full Text]
117. Lipozencić J, Wolf R. The diagnostic value of atopy patch testing and prick testing in atopic dermatitis: facts and controversies. Clin Dermatol. 2010 Jan-Feb;28(1):38-44.[Abstract]
118. National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. Aug 2020 [internet publication].[Full Text]
119. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992 Aug 6;327(6):380-4.[Abstract][Full Text]
120. Windfuhr JP, Toepfner N, Steffen G, et al. Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management. Eur Arch Otorhinolaryngol. 2016 Apr;273(4):973-87.[Abstract][Full Text]
121. Cohen JF, Bertille N, Cohen R, et al. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev. 2016 Jul 4;7(7):CD010502.[Abstract][Full Text]
122. Lean WL, Arnup S, Danchin M, et al. Rapid diagnostic tests for group A streptococcal pharyngitis: a meta-analysis. Pediatrics. 2014 Oct;134(4):771-81.[Abstract]
123. Barakat AJ, Evans C, Gill M, et al. Rapid strep testing in children with recently treated streptococcal pharyngitis. Pediatr Investig. 2019 Mar;3(1):27-30.[Abstract][Full Text]
124. World Health Organization. Diagnostic testing for the monkeypox virus (MPXV): interim guidance, 10 May 2024. May 2024 [internet publication].[Full Text]
125. UK Health Security Agency. Mpox: diagnostic testing. Sep 2024 [internet publication].[Full Text]
126. Centers for Disease Control and Prevention. Guidelines for collecting and handling specimens for mpox testing. Sep 2024 [internet publication].[Full Text]
127. McQuiston JH, Luce R, Kazadi DM, et al. U.S. preparedness and response to increasing clade I mpox cases in the Democratic Republic of the Congo - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 May 16;73(19):435-40.[Abstract][Full Text]
128. Centers for Disease Control and Prevention. Clinical overview of mpox. Sep 2024 [internet publication].[Full Text]
129. World Health Organization. WHO information notice for IVD users 2020/05. Nucleic acid testing (NAT) technologies that use polymerase chain reaction (PCR) for detection of SARS-CoV-2. Jan 2021 [internet publication].[Full Text]
130. Mork RL, Hogan PG, Muenks CE, et al. Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study. Lancet Infect Dis. 2020 Feb;20(2):188-98.[Abstract][Full Text]
Key Articles
Referenced Articles
Sign in to access our clinical decision support tools